Is ADXS or DGRO a better dividend investment in 2026?

ADXS currently yields 331.37% with a 5% 5-year dividend growth rate. DGRO yields 2.10% with 9.5% growth. The better choice depends on your goal: ADXS offers higher current income.

What is the dividend yield difference between ADXS and DGRO?

ADXS has a forward dividend yield of 331.37% ($2.00/share annually). DGRO yields 2.10% ($1.47/share annually). The yield gap is 329.27 percentage points.

Home › Compare › ADXS vs DGRO

ADXS vs DGRO: Dividend Comparison 2026

ADXS yields 331.37% · DGRO yields 2.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ADXS wins by $2987.27M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ADXS

● Live price

331.37%

Share price

$0.60

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2987.30M

Annual income

$1,874,518,858.21

Full ADXS calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.10%

Share price

$70.18

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$235.38

Full DGRO calculator →

Portfolio growth — ADXS vs DGRO

📍 ADXS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ADXS	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ADXS + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ADXS pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADXS

Annual income on $10K today (after 15% tax)

$28,166.68/yr

After 10yr DRIP, annual income (after tax)

$1,593,341,029.48/yr

DGRO

Annual income on $10K today (after 15% tax)

$178.14/yr

After 10yr DRIP, annual income (after tax)

$200.07/yr

At 15% tax rate, ADXS beats the other by $1,593,340,829.41/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADXS + DGRO for your $10,000?

ADXS: 50%DGRO: 50%

100% DGRO50/50100% ADXS

Portfolio after 10yr

$1493.67M

Annual income

$937,259,546.80/yr

Blended yield

62.75%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADXS right now

ADXS

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-24.8

Piotroski

1/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADXS buys

DGRO buys

No recent congressional trades found for ADXS or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricADXSDGRO

Forward yield	331.37% ✓	2.10%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2987.30M ✓	$31.6K
Annual income after 10y	$1,874,518,858.21 ✓	$235.38
Total dividends collected	$2879.16M ✓	$2.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ADXS vs DGRO ($10,000, DRIP)

Year	ADXS Portfolio	ADXS Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$43,837	$33,137.27	$11,290	$209.57	+$32.5K → ADXS
2	$182,667	$135,761.45	$12,722	$213.54	+$169.9K → ADXS
3	$724,155	$528,700.93	$14,314	$217.18	+$709.8K → ADXS
4	$2,733,677	$1,958,830.81	$16,080	$220.53	+$2.72M → ADXS
5	$9,835,841	$6,910,807.10	$18,040	$223.59	+$9.82M → ADXS
6	$33,762,918	$23,238,567.70	$20,215	$226.40	+$33.74M → ADXS
7	$110,677,420	$74,551,098.17	$22,627	$228.96	+$110.65M → ADXS
8	$346,821,277	$228,396,437.05	$25,302	$231.31	+$346.80M → ADXS
9	$1,039,984,991	$668,886,225.19	$28,268	$233.44	+$1039.96M → ADXS
10	$2,987,302,799	$1,874,518,858.21	$31,557	$235.38	+$2987.27M → ADXS

ADXS vs DGRO: Complete Analysis 2026

ADXS — Stock

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Full ADXS Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this ADXS vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADXS vs SCHD ADXS vs JEPI ADXS vs O ADXS vs KO ADXS vs MAIN ADXS vs VIG ADXS vs NOBL ADXS vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.